34 related articles for article (PubMed ID: 8054502)
1. Evaluation and immunohistochemical qualification of carbogen-induced ΔR₂ as a noninvasive imaging biomarker of improved tumor oxygenation.
Baker LC; Boult JK; Jamin Y; Gilmour LD; Walker-Samuel S; Burrell JS; Ashcroft M; Howe FA; Griffiths JR; Raleigh JA; van der Kogel AJ; Robinson SP
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):160-7. PubMed ID: 23849692
[TBL] [Abstract][Full Text] [Related]
2. Radiosensitization of Hs-766T Pancreatic Tumor Xenografts in Mice Dosed with Dodecafluoropentane Nano-Emulsion-Preliminary Findings.
Johnson JL; Leos RA; Baker AF; Unger EC
J Biomed Nanotechnol; 2015 Feb; 11(2):274-81. PubMed ID: 26349303
[TBL] [Abstract][Full Text] [Related]
3. Carbogen breathing differentially enhances blood plasma volume and 5-fluorouracil uptake in two murine colon tumor models with a distinct vascular structure.
van Laarhoven HW; Gambarota G; Lok J; Lammens M; Kamm YL; Wagener T; Punt CJ; van der Kogel AJ; Heerschap A
Neoplasia; 2006 Jun; 8(6):477-87. PubMed ID: 16820094
[TBL] [Abstract][Full Text] [Related]
4. In vitro anti-cancer activity of doxorubicin against human RNA helicase, DDX3.
Botlagunta M; Kollapalli B; Kakarla L; Gajarla SP; Gade SP; Dadi CL; Penumadu A; Javeed S
Bioinformation; 2016; 12(7):347-353. PubMed ID: 28246464
[TBL] [Abstract][Full Text] [Related]
5. Ketorolac salt is a newly discovered DDX3 inhibitor to treat oral cancer.
Samal SK; Routray S; Veeramachaneni GK; Dash R; Botlagunta M
Sci Rep; 2015 Apr; 5():9982. PubMed ID: 25918862
[TBL] [Abstract][Full Text] [Related]
6. Expression of DDX3 is directly modulated by hypoxia inducible factor-1 alpha in breast epithelial cells.
Botlagunta M; Krishnamachary B; Vesuna F; Winnard PT; Bol GM; Patel AH; Raman V
PLoS One; 2011 Mar; 6(3):e17563. PubMed ID: 21448281
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells.
Ahn GO; Brown JM
Cancer Cell; 2008 Mar; 13(3):193-205. PubMed ID: 18328424
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia and drug resistance.
Teicher BA
Cancer Metastasis Rev; 1994 Jun; 13(2):139-68. PubMed ID: 7923547
[TBL] [Abstract][Full Text] [Related]
9. Modulation of tumor oxygenation and radiosensitivity by a perfluorooctylbromide emulsion.
Rockwell S; Kelley M; Irvin CG; Hughes CS; Porter E; Yabuki H; Fischer JJ
Radiother Oncol; 1991 Oct; 22(2):92-8. PubMed ID: 1957007
[TBL] [Abstract][Full Text] [Related]
10. Improvement of tumor oxygenation by mild hyperthermia.
Song CW; Park H; Griffin RJ
Radiat Res; 2001 Apr; 155(4):515-28. PubMed ID: 11260653
[TBL] [Abstract][Full Text] [Related]
11. Reduced oxygenation in a rat mammary carcinoma post-radiation and reoxygenation with a perflubron emulsion/carbogen breathing.
Teicher BA; Dupuis NP; Robinson MF; Kusumoto T; Liu M; Menon K
In Vivo; 1994; 8(1):125-31. PubMed ID: 8054502
[TBL] [Abstract][Full Text] [Related]
12. Restoration of tumor oxygenation after cytotoxic therapy by a perflubron emulsion/carbogen breathing.
Teicher BA; Holden SA; Ara G; Dupuis NP; Goff D
Cancer J Sci Am; 1995; 1(1):43-8. PubMed ID: 9166453
[TBL] [Abstract][Full Text] [Related]
13. Reduced oxygenation in a rat mammary carcinoma after chemo- or radiation therapy and reoxygenation with perflubron emulsion/carbogen breathing.
Teicher BA; Sotomayor EA; Dupuis NP; Kusumoto T; Menon K
J Cancer Res Clin Oncol; 1994; 120(10):593-8. PubMed ID: 7929530
[TBL] [Abstract][Full Text] [Related]
14. Decreased tumor oxygenation after cyclophosphamide, reoxygenation and therapeutic enhancement with a perflubron emulsion carbogen breathing.
Teicher B; Dupuis N; Kusumoto T; Liu M; Liu F; Menon K; Schwartz G; Frei E
Int J Oncol; 1993 Aug; 3(2):197-203. PubMed ID: 21573348
[TBL] [Abstract][Full Text] [Related]
15. Correlation between radiosensitivity, percentage hypoxic cells and pO2 measurements in one rodent and two human tumor xenografts.
Thomas CD; Chavaudra N; Martin L; Guichard M
Radiat Res; 1994 Jul; 139(1):1-8. PubMed ID: 8016297
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
